| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 914 securities · passive | ||||||
|
Keros Therapeutics, Inc.
13G/A
KROS · 492327101
|
1.7% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 1.7% | |||||
| Abigail P. Johnson | 1.7% | |||||
|
Intra-Cellular Therapies Inc.
13G/A
ITCI · 46116X101
|
2.5% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 2.5% | |||||
| Abigail P. Johnson | 2.5% | |||||
|
Real Good Food Co Inc/The
13G/A
RGFC · 75601G307
|
2.5% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 2.5% | |||||
| Abigail P. Johnson | 2.5% | |||||
|
RAPT Therapeutics, Inc.
13G/A
RAPT · 75382E109
|
0.4% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 0.4% | |||||
| Abigail P. Johnson | 0.4% | |||||
|
Arch Resources, Inc.
13G/A
ARCH · 03940R107
|
0% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 0% | |||||
| Abigail P. Johnson | 0% | |||||
|
JPMorgan International Research Enhanced Equity ETF
13G/A
JIRE · 46641Q134
|
2.5% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 2.5% | |||||
| Abigail P. Johnson | 2.5% | |||||
|
Candel Therapeutics, Inc.
13G/A
CADL · 137404109
|
15.0% |
2/7/2025
Event 1/31/2025
|
||||
| FMR LLC | 15.0% | |||||
| Abigail P. Johnson | 15.0% | |||||
|
Real Good Food Co Inc/The
13G/A
RGF · 75601G109
|
12.3% |
2/7/2025
Event 12/31/2024
|
||||
| FMR LLC | 12.3% | |||||
| Abigail P. Johnson | 12.3% | |||||
|
Utah Medical Products, Inc.
13G/A
UTMD · 917488108
|
2.7% |
1/8/2025
Event 12/31/2024
|
||||
| FMR LLC | 2.7% | |||||
| Abigail P. Johnson | 2.7% | |||||
|
CONSOL Energy Inc.
13G
CEIX · 20854L108
|
11.2% |
1/8/2025
Event 12/31/2024
|
||||
| FMR LLC | 11.2% | |||||
| Abigail P. Johnson | 11.2% | |||||
|
Liberty Broadband Corp
13G/A
LBRDA · 530307107
|
4.7% |
1/8/2025
Event 12/31/2024
|
||||
| FMR LLC | 4.7% | |||||
| Abigail P. Johnson | 4.7% | |||||
|
Oncology Institute Inc/The
13G/A
STLN · 68236X100
|
0% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 0% | |||||
| Abigail P. Johnson | 0% | |||||
|
Primo Water Corp
13G/A
PRMW · 74167P108
|
0% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 0% | |||||
| Abigail P. Johnson | 0% | |||||
|
Kosmos Energy Ltd.
13G/A
KOS · 500688106
|
2.1% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 2.1% | |||||
| Abigail P. Johnson | 2.1% | |||||
|
Zentalis Pharmaceuticals, Inc.
13G/A
ZNTL · 98943L107
|
0.2% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 0.2% | |||||
| Abigail P. Johnson | 0.2% | |||||
|
Altice USA, Inc.
13G/A
OPTU · 02156K103
|
1.0% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 1.0% | |||||
| Abigail P. Johnson | 1.0% | |||||
|
ALX Oncology Holdings Inc.
13G/A
ALXO · 00166B105
|
3.4% |
12/6/2024
Event 11/29/2024
|
||||
| FMR LLC | 3.4% | |||||
| Abigail P. Johnson | 3.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.